BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 1 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $77,343,000 | +320.7% | 1,464 | +388.0% | 0.00% | – |
Q2 2020 | $18,384,000 | -83.0% | 300 | -84.3% | 0.00% | – |
Q1 2020 | $107,879,000 | +104.4% | 1,907 | +105.7% | 0.00% | – |
Q4 2019 | $52,783,000 | +3.4% | 927 | -2.8% | 0.00% | – |
Q3 2019 | $51,058,000 | +31.1% | 954 | +46.3% | 0.00% | – |
Q2 2019 | $38,931,000 | -48.2% | 652 | -45.9% | 0.00% | – |
Q1 2019 | $75,108,000 | +61972.7% | 1,205 | +60150.0% | 0.00% | – |
Q4 2018 | $121,000 | -98.9% | 2 | -98.9% | 0.00% | – |
Q3 2018 | $10,528,000 | +30.4% | 180 | 0.0% | 0.00% | – |
Q2 2018 | $8,075,000 | -84.4% | 180 | -84.6% | 0.00% | – |
Q1 2018 | $51,745,000 | +8.0% | 1,167 | +5.5% | 0.00% | – |
Q4 2017 | $47,923,000 | +119.6% | 1,106 | +135.8% | 0.00% | – |
Q3 2017 | $21,818,000 | -21.4% | 469 | -16.4% | 0.00% | – |
Q2 2017 | $27,775,000 | +1366.5% | 561 | +1550.0% | 0.00% | – |
Q4 2016 | $1,894,000 | -89.7% | 34 | -91.5% | 0.00% | – |
Q3 2016 | $18,314,000 | +117.3% | 401 | +90.0% | 0.00% | – |
Q2 2016 | $8,427,000 | +611.7% | 211 | +520.6% | 0.00% | – |
Q1 2016 | $1,184,000 | -97.3% | 34 | -96.7% | 0.00% | – |
Q4 2015 | $44,602,000 | +5.0% | 1,038 | +6.4% | 0.00% | – |
Q3 2015 | $42,495,000 | +100.9% | 976 | +138.0% | 0.00% | – |
Q2 2015 | $21,156,000 | +487.3% | 410 | +345.7% | 0.00% | – |
Q1 2015 | $3,602,000 | -17.7% | 92 | -25.8% | 0.00% | – |
Q3 2014 | $4,377,000 | -0.8% | 124 | -33.3% | 0.00% | – |
Q1 2014 | $4,414,000 | +9.5% | 186 | 0.0% | 0.00% | – |
Q4 2013 | $4,031,000 | – | 186 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|